|
|
|
Do antiseptic coated central lines prevent catheter-related bloodstream infection?
Lead author's name: Jaeger K
3-part Clinical Question Patients: had haematological malignancy Intervention: Antiseptic impregnation with silver sulphadiazine and chlorhexidine or untreated central venous catheters Outcomes: catheter colonisation and catheter related bloodstream infection (CRBSI)
Search Terms: intensive care, critical care, central venous catheters, infection, prevention, controlled trial.
The Study: Unblinded randomised controlled trial with intention-to treat analysis
The Study Patients:
Control group (standard CVC) n= 55; all analysed Experimental group (impregnated CVC) n= 51; all analysed
The Evidence:
EBM questions:
1) Do the methods allow accurate testing of the hypothesis? Yes.
2) Do the statistical tests correctly test the results to allow differentiation of statistically significant results? Yes
3) Are conclusions valid in light of the results? Yes
4) Did results get omitted, and why? No
5) Did they suggest areas of further research? No
6) Did they make any recommendations based on the results and were they appropriate? No
7) Is the study relevant to my clinical practice? Perhaps not, haematology patients have a much higher incidence of CRBSIs (~15 v. 5%), so the NNT is relatively low
8) What level of evidence does this study represent? 1-
9) What grade of recommendation can I make on this result alone? N/A
10) What grade of recommendation can I make when this study is considered along with other available evidence? A – see topic summary
11) Should I change my practice because of these results? Perhaps- it depends on your views about the validity and importance of pooled analysis of RCTs
12) Should I audit my current practice because of these results? No, but you should be auditing CRBSI rates anyway.
Appraised by Dr David Swann, Consultant, ICU, Royal Infirmary of Edinburgh. June 2005
Email: d.g.swann@ad.ac.uk
Edited by CC Kill by Date: 2010
©SICS EBMG 2002
| |||||||||||||||||||||||